EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)

EGX:NIPH Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	4,800	1,465	699	405	359	354
Market Cap Growth	799.23%	109.54%	72.69%	12.78%	1.40%	14.77%
Enterprise Value	6,009	2,282	1,009	670	317	305
Last Close Price	96.00	32.01	16.84	9.08	7.38	6.76
PE Ratio	11.80	11.65	7.75	3.40	4.00	5.50
PS Ratio	2.60	1.14	0.61	0.40	0.41	0.47
PB Ratio	4.57	1.97	1.49	0.85	0.83	0.95
P/TBV Ratio	4.57	1.97	1.49	0.85	0.83	0.95
P/FCF Ratio	-	-	-	-	-	4.72
P/OCF Ratio	-	1568.74	2.65	-	73.13	4.46
EV/Sales Ratio	3.25	1.77	0.88	0.67	0.36	0.40
EV/EBITDA Ratio	12.17	7.41	6.49	1.36	2.28	2.84
EV/EBIT Ratio	13.38	8.17	7.03	4.11	2.53	3.19
EV/FCF Ratio	-10.42	-	-	-	-	4.07
Debt / Equity Ratio	1.17	1.33	1.23	0.44	0.19	0.12
Debt / EBITDA Ratio	2.48	3.21	3.70	0.43	0.57	0.40
Debt / FCF Ratio	-	-	-	-	-	0.58
Asset Turnover	0.71	0.68	0.91	1.11	1.18	1.08
Inventory Turnover	2.32	1.82	2.08	2.26	2.62	2.09
Quick Ratio	0.36	0.38	0.35	0.47	0.57	0.74
Current Ratio	1.10	0.98	1.28	1.75	1.81	1.75
Return on Equity (ROE)	32.38%	20.75%	19.05%	26.22%	22.36%	18.16%
Return on Assets (ROA)	10.71%	9.20%	7.14%	11.25%	10.53%	8.54%
Return on Invested Capital (ROIC)	17.67%	15.82%	14.25%	23.69%	25.38%	24.88%
Return on Capital Employed (ROCE)	29.80%	25.00%	17.80%	30.10%	28.90%	25.50%
Earnings Yield	5.08%	8.58%	12.90%	29.44%	24.98%	18.19%
FCF Yield	-12.01%	-32.28%	-22.25%	-70.16%	-12.21%	21.21%
Dividend Yield	2.06%	6.25%	22.04%	55.09%	40.27%	29.57%
Payout Ratio	20.31%	39.41%	71.36%	34.95%	37.13%	70.73%
Buyback Yield / Dilution	-196.30%	-196.30%	-	-	-	-
Total Shareholder Return	-194.24%	-190.05%	22.04%	55.09%	40.27%	29.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.